Variant report

Variant	esv3346985
Chromosome Location	chr2:30369298-30371696
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:854)
CpG islands
(count:858)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:854 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:30370782-30370881	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:30369311-30369561	K562	blood:	n/a	n/a
3	ARID3A	chr2:30369229-30369901	HepG2	liver:	n/a	n/a
4	ATF1	chr2:30369217-30369838	K562	blood:	n/a	n/a
5	ATF2	chr2:30369062-30369768	GM12878	blood:	n/a	n/a
6	ATF3	chr2:30369225-30369638	K562	blood:	n/a	n/a
7	ATF3	chr2:30370597-30370911	K562	blood:	n/a	n/a
8	ATF3	chr2:30370687-30370877	GM12878	blood:	n/a	n/a
9	ATF3	chr2:30370550-30370998	GM12878	blood:	n/a	n/a
10	ATF3	chr2:30370564-30370934	HepG2	liver:	n/a	n/a
11	ATF3	chr2:30370101-30370496	K562	blood:	n/a	n/a
12	ATF3	chr2:30370468-30371040	HepG2	liver:	n/a	n/a
13	ATF3	chr2:30370606-30370963	H1-hESC	embryonic stem cell:	n/a	n/a
14	BACH1	chr2:30369276-30369591	K562	blood:	n/a	n/a
15	BACH1	chr2:30369262-30370104	H1-hESC	embryonic stem cell:	n/a	n/a
16	BACH1	chr2:30370897-30370911	H1-hESC	embryonic stem cell:	n/a	n/a
17	BCL3	chr2:30369165-30369994	A549	lung:	n/a	chr2:30369767-30369776
18	BCL3	chr2:30369050-30370121	A549	lung:	n/a	chr2:30369767-30369776 chr2:30370037-30370046
19	BHLHE40	chr2:30369220-30369655	A549	lung:	n/a	n/a
20	BHLHE40	chr2:30368862-30370056	K562	blood:	n/a	n/a
21	BHLHE40	chr2:30369115-30369593	HepG2	liver:	n/a	n/a
22	BHLHE40	chr2:30370489-30370988	GM12878	blood:	n/a	n/a
23	BHLHE40	chr2:30368861-30369864	GM12878	blood:	n/a	n/a
24	BHLHE40	chr2:30369171-30369890	HepG2	liver:	n/a	n/a
25	BHLHE40	chr2:30370597-30370942	K562	blood:	n/a	n/a
26	BRCA1	chr2:30369134-30369544	HepG2	liver:	n/a	n/a
27	BRCA1	chr2:30371560-30372091	Hela-S3	cervix:	n/a	n/a
28	BRCA1	chr2:30369209-30369693	Hela-S3	cervix:	n/a	n/a
29	CBX3	chr2:30369178-30369911	K562	blood:	n/a	n/a
30	CCNT2	chr2:30369080-30371315	K562	blood:	n/a	chr2:30369709-30369718 chr2:30369566-30369575 chr2:30369670-30369679
31	CEBPB	chr2:30369197-30369838	MCF-7	breast:	n/a	chr2:30369534-30369542
32	CEBPB	chr2:30369325-30369716	K562	blood:	n/a	chr2:30369534-30369542
33	CEBPB	chr2:30369184-30369778	K562	blood:	n/a	chr2:30369534-30369542
34	CEBPB	chr2:30369355-30369713	HepG2	liver:	n/a	chr2:30369534-30369542
35	CEBPB	chr2:30369445-30369700	HepG2	liver:	n/a	chr2:30369534-30369542
36	CEBPB	chr2:30369097-30370032	HCT-116	colon:	n/a	chr2:30369534-30369542
37	CEBPB	chr2:30369338-30369756	H1-hESC	embryonic stem cell:	n/a	chr2:30369534-30369542
38	CEBPB	chr2:30369050-30369876	Hela-S3	cervix:	n/a	chr2:30369534-30369542
39	CEBPB	chr2:30368923-30369848	HepG2	liver:	n/a	chr2:30369534-30369542
40	CEBPB	chr2:30369222-30369818	A549	lung:	n/a	chr2:30369534-30369542
41	CEBPB	chr2:30369405-30369680	ECC-1	luminal epithelium:	n/a	chr2:30369534-30369542
42	CEBPB	chr2:30369264-30369881	MCF-7	breast:	n/a	chr2:30369534-30369542
43	CEBPB	chr2:30369225-30369825	ECC-1	luminal epithelium:	n/a	chr2:30369534-30369542
44	CEBPB	chr2:30368979-30369897	A549	lung:	n/a	chr2:30369534-30369542
45	CEBPB	chr2:30369173-30369861	IMR90	lung:	n/a	chr2:30369534-30369542
46	CEBPB	chr2:30369300-30369770	K562	blood:	n/a	chr2:30369534-30369542
47	CEBPB	chr2:30369084-30369888	A549	lung:	n/a	chr2:30369534-30369542
48	CEBPB	chr2:30369290-30370067	HepG2	liver:	n/a	chr2:30369534-30369542
49	CEBPD	chr2:30369406-30369712	HepG2	liver:	n/a	n/a
50	CEBPD	chr2:30369169-30370061	HepG2	liver:	n/a	n/a

(count:858 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:30369584-30369634	BE2_C	brain:	n/a
2	chr2:30369314-30369364	HRE	kidney:	n/a
3	chr2:30369314-30369364	T-47D	breast:	n/a
4	chr2:30369314-30369364	BE2_C	brain:	n/a
5	chr2:30369584-30369634	BE2_C	brain:	n/a
6	chr2:30369314-30369364	HRE	kidney:	n/a
7	chr2:30369314-30369364	T-47D	breast:	n/a
8	chr2:30369314-30369364	BE2_C	brain:	n/a
9	chr2:30370629-30370679	T-47D	breast:	n/a
10	chr2:30369896-30369946	PANC-1	pancreas:	n/a
11	chr2:30369896-30369946	PrEC	prostate:	n/a
12	chr2:30370168-30370218	HRE	kidney:	n/a
13	chr2:30369571-30369621	GM12891	blood:	n/a
14	chr2:30370168-30370218	HEK293	kidney:	embryo
15	chr2:30369584-30369634	RPTEC	kidney:	n/a
16	chr2:30369455-30369505	HRPEpiC	eye:	n/a
17	chr2:30370168-30370218	HRPEpiC	eye:	n/a
18	chr2:30370168-30370218	GM19239	blood:	n/a
19	chr2:30369382-30369432	Caco-2	colon:	n/a
20	chr2:30369896-30369946	AG04449	skin:	fetal
21	chr2:30371369-30371419	AG04450	lung:	fetal
22	chr2:30369455-30369505	AG10803	skin:	n/a
23	chr2:30371484-30371534	ovcar-3	ovarian:	n/a
24	chr2:30369779-30369829	HMEC	breast:	n/a
25	chr2:30369455-30369505	ECC-1	luminal epithelium:	n/a
26	chr2:30371484-30371534	PFSK-1	brain:	n/a
27	chr2:30369571-30369621	NB4	blood:	n/a
28	chr2:30369763-30369813	HepG2	liver:	n/a
29	chr2:30370168-30370218	GM12891	blood:	n/a
30	chr2:30370168-30370218	T-47D	breast:	n/a
31	chr2:30369584-30369634	PFSK-1	brain:	n/a
32	chr2:30369576-30369626	MCF10A-Er-Src	breast:	n/a
33	chr2:30369571-30369621	HCM	heart:	n/a
34	chr2:30370168-30370218	HEEpiC	esophagus:	n/a
35	chr2:30369584-30369634	ovcar-3	ovarian:	n/a
36	chr2:30370629-30370679	HMEC	breast:	n/a
37	chr2:30369896-30369946	LNCaP	prostate:	n/a
38	chr2:30370632-30370682	HCT-116	colon:	n/a
39	chr2:30369896-30369946	BE2_C	brain:	n/a
40	chr2:30369576-30369626	ovcar-3	ovarian:	n/a
41	chr2:30369576-30369626	GM12878	blood:	n/a
42	chr2:30369314-30369364	K562	blood:	n/a
43	chr2:30369779-30369829	HEK293	kidney:	embryo
44	chr2:30371484-30371534	SAEC	small airway:	n/a
45	chr2:30371484-30371534	HCPEpiC	choroid plexus:	n/a
46	chr2:30369584-30369634	HAEpiC	amniotic membrane:	n/a
47	chr2:30370168-30370218	PrEC	prostate:	n/a
48	chr2:30370629-30370679	MCF-7	breast:	n/a
49	chr2:30369314-30369364	NHBE	bronchial:	n/a
50	chr2:30369382-30369432	BJ	skin:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:30369876..30376242-chr2:30376921..30381158,8	K562	blood:
2	chr2:30370893..30374119-chr2:30453845..30456707,3	K562	blood:
3	chr2:30370673..30372393-chr2:30454162..30455838,3	K562	blood:
4	chr2:30366474..30375732-chr2:30375765..30384167,14	MCF-7	breast:
5	chr2:30368663..30370783-chr2:30453321..30456156,2	K562	blood:
6	chr2:30357579..30360858-chr2:30368602..30370618,3	MCF-7	breast:
7	chr2:30361445..30366413-chr2:30367443..30370864,6	MCF-7	breast:
8	chr2:30371465..30373484-chr2:30397910..30400292,3	K562	blood:
9	chr2:30362220..30364424-chr2:30369262..30372123,2	K562	blood:
10	chr2:30369470..30372362-chr2:30669050..30670728,2	MCF-7	breast:
11	chr2:30337518..30339089-chr2:30368226..30369771,2	K562	blood:

No data

Variant related genes	Relation type
YPEL5	TF binding region
ENSG00000233862	TF binding region
YPEL5	CpG island
ENSG00000233862	CpG island
ENSG00000172954	chromatin interactions
ENSG00000119801	chromatin interactions
ENSG00000213626	chromatin interactions
ENSG00000233862	chromatin interactions

Extended variants
information (count: 85 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:85 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374349402	chr2:30369356-30369357	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs562136364	chr2:30369361-30369362	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs114004281	chr2:30369362-30369363	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs544774699	chr2:30369377-30369378	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs564660470	chr2:30369385-30369386	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs533728988	chr2:30369399-30369400	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs572440112	chr2:30369403-30369404	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs148426211	chr2:30369415-30369416	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs559331599	chr2:30369417-30369418	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs376077071	chr2:30369446-30369447	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs528039159	chr2:30369469-30369470	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs547901791	chr2:30369473-30369474	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs186112377	chr2:30369516-30369517	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs530514867	chr2:30369579-30369580	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs550411132	chr2:30369612-30369613	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs371307615	chr2:30369617-30369618	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs570535896	chr2:30369645-30369646	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs2276548	chr2:30369660-30369661	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs545160040	chr2:30369663-30369664	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs552958288	chr2:30369687-30369688	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs566880616	chr2:30369699-30369700	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs35039108	chr2:30369702-30369703	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs12470512	chr2:30369708-30369709	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs555906032	chr2:30369766-30369767	Weak transcription Active TSS Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs372367909	chr2:30369805-30369806	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs11689346	chr2:30369808-30369809	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs139589300	chr2:30369815-30369816	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs558358385	chr2:30369831-30369832	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs560680038	chr2:30369844-30369845	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs578096211	chr2:30369851-30369852	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs540933565	chr2:30369854-30369855	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs560593063	chr2:30369896-30369897	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs565437766	chr2:30369911-30369912	Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs374099750	chr2:30370091-30370092	Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs528077456	chr2:30370135-30370136	Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs541467574	chr2:30370151-30370152	Weak transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs561345406	chr2:30370233-30370234	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs530549862	chr2:30370270-30370271	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs550248074	chr2:30370272-30370273	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs570641041	chr2:30370295-30370296	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs532954812	chr2:30370324-30370325	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs546877240	chr2:30370432-30370433	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs12987354	chr2:30370478-30370479	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs566610537	chr2:30370496-30370497	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs535736169	chr2:30370536-30370537	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs572448701	chr2:30370552-30370553	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs115948611	chr2:30370560-30370561	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs188962590	chr2:30370579-30370580	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs200712233	chr2:30370596-30370597	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs112115382	chr2:30370694-30370695	Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Autism	22495311	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Medulloblastoma	16968546	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Breast cancer	21364760	CNVD
Wilms tumour	21544195	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	18927303	CNVD
Hepatocellular carcinoma	16750200	CNVD
Lung cancer	16740712	CNVD
Hereditary gingival fibromatosis	19633868	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Tetralogy of Fallot	22912587	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:30368600-30369400	Flanking Active TSS	Primary hematopoietic stem cells	blood
2	chr2:30368600-30369400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr2:30368600-30369400	Flanking Active TSS	GM12878-XiMat	blood
4	chr2:30368600-30370800	Active TSS	Fetal Brain Female	brain
5	chr2:30368600-30371200	Active TSS	Brain Angular Gyrus	brain
6	chr2:30368800-30369400	Active TSS	ES-I3 Cell Line	embryonic stem cell
7	chr2:30368800-30369400	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr2:30368800-30369400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr2:30368800-30369400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr2:30368800-30369400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
11	chr2:30368800-30369400	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
12	chr2:30368800-30369400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
13	chr2:30368800-30369400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr2:30368800-30369400	Flanking Active TSS	Adipose Nuclei	Adipose
15	chr2:30368800-30369400	Flanking Active TSS	Brain Cingulate Gyrus	brain
16	chr2:30368800-30369400	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
17	chr2:30368800-30369400	Flanking Active TSS	Fetal Intestine Large	intestine
18	chr2:30368800-30369400	Flanking Active TSS	Fetal Thymus	thymus
19	chr2:30368800-30369400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
20	chr2:30368800-30369400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
21	chr2:30368800-30369400	Flanking Active TSS	Dnd41	blood
22	chr2:30368800-30369400	Flanking Active TSS	Hela-S3	cervix
23	chr2:30368800-30369400	Flanking Bivalent TSS/Enh	HepG2	liver
24	chr2:30368800-30369400	Flanking Active TSS	HUVEC	blood vessel
25	chr2:30368800-30369400	Flanking Active TSS	K562	blood
26	chr2:30368800-30369400	Flanking Active TSS	NHLF	lung
27	chr2:30368800-30369400	Flanking Active TSS	Osteobl	bone
28	chr2:30368800-30369800	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr2:30368800-30371000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
30	chr2:30368800-30371000	Active TSS	Skeletal Muscle Female	skeletal muscle
31	chr2:30368800-30371200	Active TSS	Breast Myoepithelial Primary Cells	Breast
32	chr2:30368800-30371200	Active TSS	Brain Anterior Caudate	brain
33	chr2:30369000-30369400	Flanking Active TSS	H1 Cell Line	embryonic stem cell
34	chr2:30369000-30369400	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr2:30369000-30369400	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr2:30369000-30369400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
37	chr2:30369000-30369400	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr2:30369000-30369400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
39	chr2:30369000-30369400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
40	chr2:30369000-30369400	Flanking Active TSS	Liver	Liver
41	chr2:30369000-30369400	Flanking Active TSS	Fetal Lung	lung
42	chr2:30369000-30369400	Flanking Active TSS	Fetal Muscle Trunk	muscle
43	chr2:30369000-30369400	Flanking Active TSS	Fetal Muscle Leg	muscle
44	chr2:30369000-30369400	Flanking Active TSS	Placenta	Placenta
45	chr2:30369000-30369400	Flanking Active TSS	Fetal Stomach	stomach
46	chr2:30369000-30369400	Flanking Active TSS	Stomach Smooth Muscle	stomach
47	chr2:30369000-30369400	Flanking Active TSS	HSMM	muscle
48	chr2:30369000-30369400	Flanking Active TSS	HSMMtube	muscle
49	chr2:30369000-30369400	Flanking Active TSS	NH-A	brain
50	chr2:30369000-30369800	Active TSS	Primary T helper naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links